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BACKGROUND: In various centres a diabetes management team (DMT) was 
found to have an impact on glycaemic control. 
HYPOTHESIS: A DMT improves HbA1c levels, decreases the diabetic 
ketoacidosis (DKA) and recurrent DKA (rDKA) rates, reduces admissions, 
shortens the length of hospital stay, improves clinic attendance rate, leads to 
a reduced dose of insulin per patient, facilitates the use of an intensive insulin 
regimen and decreases the prevalence of complications of type 1 diabetic 
(T1DM) paediatric and adolescent patients attending Tygerberg Children’s 
Hospital (TCH). 
STUDY DESIGN: Retrospective cohort study (a time series) with cross-
sectional elements. 
METHODS: 190 T1DM patients attending the paediatric diabetic clinic at TCH 
between August 2004 and July 2011 were reviewed. Data extracted: HbA1c 
levels, DKA and rDKA admissions, total number of admissions, length of 
hospital stay, clinic attendances, insulin regimen and dose, and complications. 
4 time periods were compared: P1 (paediatric endocrinologist only), P2 
(introduction of DMT after a period when no paediatric endocrinologist was 
available), P3 [introduction of diabetes nurse educator (DNE)], and P4 
(substitution of DNE). 
RESULTS: HbA1c increased from 9% (95% CI 7.85-10.15) in P1 to 10.9% 
(95% CI 9.6-12.2) in P2, and decreased to 9.25% (95% CI 8.75-9.75) in P4 
(p=0.01818). DKA rate improved from 32.5 (P1) to 23.5 /100 patient years 
(P4). Recurrent DKA rate improved from 18.8% (P1) to 9.6% (P4). 
Admissions decreased from 0.79 (95% CI 0.46-1.12) in P1 to 0.18 (95% CI 
0.02-0.34) in P4 (p=0.00127). Patients hospitalised for longer than 30 days 
decreased from 30% (P2) to 15.1 % (P4). Number of insulin injections 
increased from 2.97 (95% CI 2.91-3.03) in P1, to 3.06 (95% CI 2.97-3.14) in 
P2 but remained constant thereafter (p=0.0015). Few complications were 
documented in P1. Prevalence of microalbuminuria was similar (95% CI 26.9-
46.2%) in all periods, as was retinopathy (95% CI 10.3-13.3%). Prevalence of 
limited joint mobility (LJM) increased from 26% (P2) to 42.9% (P4). Levels of 
triglycerides were similar in all periods, low-density lipoprotein cholesterol 
(LDLC) decreased to 2.6mmol/l (95% CI 2.38-2.81) in P3 and high-density 
lipoprotein cholesterol (HDLC) decreased to 1.38mmol/l (95% CI 1.27-1.49) in 
P4. 
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CONCLUSIONS: After introduction of the full DMT (including the DNE), 
HbA1c decreased and showed less variation, DKA and rDKA rate decreased, 
hospital stay shortened, number of insulin injections/day increased and 
complications were more readily identified. Decreased clinic attendance 
corresponded to poorer glycaemic control and the period where inexperienced 
personnel were responsible for diabetes care. There was an increase in 
usage of both the modified conventional regimen as well as the basal bolus 
regimen as time progressed. It is therefore recommended that the services of 
the DMT, which includes a DNE, should continue. 
.  
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AGTERGROND: Verskeie sentrums het vantevore bevind dat 'n diabetiese 
bestuurspan (DBS) 'n impak op glukemiese beheer het. 
HIPOTESE: ŉ DBS verlaag HbA1c vlakke, verminder diabetiese ketoasidose (DKA) 
en herhalende DKA (hDKA) episodes, verminder hospitaal toelatings, verkort 
hospitaal verblyf, verbeter kliniek bywoning, lei tot 'n verminderde dosis insulien 
gebruik per pasiënt, fasiliteer die gebruik van 'n intensiewe insulien skedule en, 
verminder die voorkoms van komplikasies van  tipe 1-diabetes (T1DM) in pediatriese 
en adolessente pasiënte wat Tygerberg Kinder Hospitaal (TKH) besoek. 
STUDIE-ONTWERP: Terugwerkende Kohort studie ('n tyd reeks) met deursnee-
elemente. 
METODE: Die bywoning van 190 T1DM pasiënte by die pediatriese diabetese kliniek 
by TKH tussen Augustus 2004 en Julie 2011 is nagegaan. Die volgende data is 
versamel: HbA1c vlakke, DKA en hDKA opnames, die totale aantal opnames, die 
lengte van hospitaal verblyf, kliniek bywoning, insulien skedule, insulien dosis,en 
komplikasies. Vier tydperke is met mekaar vergelyk: P1 (net pediatriese 
endokrinoloog), P2 (bekendstelling van DBS na ‘n periode waar daar geen 
pediatriese endokrinoloog was nie), P3 [bekendstelling van diabetiese verpleegster 
opvoeder (DVO)], en P4 (vervanging van DVO). 
RESULTATE: HbA1c het toegeneem van 9% (95% CI 7,85-10,15) in P1 tot 10.9% 
(95% CI 9,6-12,2) in P2, en het verminder na 9,25% (95% CI 8,75-9,75) in P4 (p = 
0,01818). DKA voorkoms het verbeter van 32.5 (P1) na 23.5 / 100 pasiënt jare (P4). 
HDKA het verbeter van 18,8% (P1) tot 9.6% (P4). Toelatings het afgeneem van 0,79 
(95% CI 0,46-1,12) in P1 tot 0,18 (95% CI 0,02-0,34) in P4 (p = 0,00127). Die aantal 
pasiënte wat gehospitaaliseer was vir langer as 30 dae het verminder van 30% (P2) 
na 15,1% (P4). Die hoeveelheid insulien inspuitings het toegeneem van 2,97 (95% 
CI 2.91-3.03) in P1, na 3,06 (95% CI 2,97-3,14) in P2, maar het daarna konstant 
gebly (p=0,0015). Min komplikasies is gedokumenteer vir P1. Die voorkoms van 
mikroalbuminurie was soortgelyk (95% CI 26,9-46,2%) in al die tydperke, asook 
retinopatie (95% CI 10,3-13,3%). Voorkoms van beperkte gewrigsmobiliteit het 
verhoog vanaf 26% (P2) na 42,9% (P4). Vlakke van trigliseriede was soortgelyk in al 
die tydperke, lae-digtheid lipoproteïen cholesterol het afgeneem na 2.6mmol / l (95% 
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CI 2,38-2,81) in P3 en hoë-digtheid lipoproteïen cholesterol het afgeneem na 
1.38mmol / l (95% CI 1,27-1,49) in P4. 
GEVOLGTREKKING: Na bekendstelling van die volle DBS (insluitend die DVO), het 
HbA1c verlaag en meer konstant vertoon, DKA en hDKA syfers het gedaal, hospitaal 
verblyf het verkort, die hoeveelheid van insulieninspuitings per dag het verhoog en 
komplikasies is makliker geïdentifiseer. Verminderde kliniek bywonings 
korrespondeer met slegte glukemiese beheer en met die periode waar onervare 
personeel verantwoorelik was vir diabetiese sorg. Daar was ‘n toeneming in die 
gebruik van albei die gemodifiseerde konvensionele regimen en die basale bolus 
regimen. Ons beveel dus aan dat die dienste van die DBS, insluitend ‘n DVO moet 
voortgaan. 
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Type 1 diabetes mellitus is amongst the most frequent chronic non-infectious 
diseases occurring in children [1, 2]. There appears to be a worldwide 
increase in type 1 diabetes in children and adolescents, the epidemiology of 
which remains largely unknown [3]. The incidence of type 1 diabetes is 
currently estimated at 5/100 000 new cases in the Western Cape compared to 
2-35/100 000 new cases worldwide [4]. However, literature on diabetic 
complications and metabolic control in children and adolescents in the 
Western Cape is very limited. Literature regarding diabetes in Africa is also 
quite limited due to poor infrastructure and inadequate training of healthcare 
workers [5]. 
 
Once a patient is diagnosed with type 1 diabetes, it is important to obtain 
adequate metabolic control, so as to limit or delay the progression of 
complications as a result of the disease [6]. Metabolic control and early 
diagnosing of complications in type 1 diabetics could be improved by 
implementing a multi-disciplinary approach involving a diabetic specialist, 
diabetic educator, dietician and social worker as per the ISPAD (International 
Society for Pediatric and Adolescent Diabetes) clinical practice consensus 
guidelines [7, 8]. A study done by F.J. Cowan et al at the University Hospital 
of Wales also demonstrated a reduction in outpatient clinic non-attendance 
rate, length of hospital stay, median hospital stay at diagnosis and admission 
rates, a year after implementation of a DNE [9]. 
 
At TCH, a DMT (new paediatric endocrinologist, a dietician and social worker) 
was introduced in August 2007 whereas a dedicated DNE for paediatrics was 
only appointed in August 2009. These interventions are expected to improve 
metabolic control and clinic attendance as well as reduce hospital admissions, 
length of hospital stay and prevalence of complications, thus improving quality 
of life in these patients. 
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2 LITERATURE REVIEW 
 
  
Glycosylated Haemoglobin (HbA1c) levels are used as the marker of long-
term metabolic control, a predictor of the risk of development of complications 
in type 1 diabetics [10], and are a reliable method for diagnosing type 1 
diabetes in both children and adolescents [11]. The American Diabetes 
Association, International Expert Committee and World Health Organisation 
currently recommend an HbA1c level of > 6.5% to diagnose diabetes. 
However, the low sensitivity, higher cost and limited availability in developing 
countries compared to blood glucose levels currently make it an inappropriate 
diagnostic tool in these countries [12]. Good metabolic control is defined as an 
HbA1c level of < 7.5% as per the ISPAD clinical practice consensus 
guidelines of the year 2000 and 2009 [6, 7, 10].  An HbA1c level of 7.5-9.0% 
and >9% is considered as moderate and poor metabolic control, respectively 
[13]. However, many international studies [2], as well as African studies 
performed in Tanzania and Rwanda [5, 14], reveal that the recommended 
HbA1c level is seldom reached, due to numerous factors including patient-
related and/or treatment-related factors [2, 5, 14]. Influencing factors in 
international studies include patient age, gender, ethnicity and socioeconomic 
status; follow-up centres and number of diabetic clinic visits. Increased HbA1c 
levels were associated with pubertal age as well as adolescents, female 
gender, ethnic minority status, poor socioeconomic status and fewer diabetic 
clinic visits [2]. African studies suggest that worse glycaemic control is 
associated with fewer clinic visits, longer diabetes duration and male gender 
as well as unstandardized management approaches. Lack of infrastructure 
resulting in poorly stored insulin as well as lack of adequate supply of glucose 
testing materials could also play a role in poorer glycaemic control [5]. A study 
by E.-M.Gerstl et al in 2008 in Germany and Austria suggests that HbA1c 
levels > 7.5% are especially associated with an increased risk of development 
of microvascular complications [2].  
 
Complications of type 1 diabetes mellitus could be categorised as 
microvascular or macrovascular [8]. Microvascular complications include 
diabetic retinopathy, nephropathy and neuropathy [15] whereas 
macrovascular complications include myocardial infarction and 
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cerebrovascular accident. Other associations include hypertension, 
hypercholesterolaemia, limited joint mobility, poor growth and high body mass 
index (BMI), the latter two factors being found more commonly in pubertal 
females. 
 
Numerous studies including the Diabetes Control and Complications Trial 
(DCCT) have obtained data which suggests that improved glycaemic control 
as reflected by lower HbA1c levels, results in a reduced incidence of 
microvascular complications [2, 6, 8, 16] as well as a reduction in the 
progression of these complications. In the DCCT, every 10% reduction in the 
HbA1c reduced the risk of retinopathy progression by approximately 44%, 
microalbuminuria by 25% and clinical neuropathy by 30% in patients older 
than 13 years of age [16]. 
 
Diabetic retinopathy appears to be the most prevalent microvascular 
complication occurring in children and adolescents with type 1 diabetes. The 
prevalence appears to increase dramatically between five and fifteen years of 
diabetes and reaches a plateau in 80%-100% of patients after twenty years 
diabetes duration [17]. Diabetic retinopathy can be divided into an early non-
proliferative (background) stage and a later proliferative stage [18]. However, 
studies demonstrating the prevalence of each individual category are very 
rare, even more so in children and adolescents. 
 
In 1998, a study by R.W. Holl et al, demonstrated the prevalence of mild non-
proliferative retinopathy in paediatric type 1 diabetics to be 16.3% of which 
54% were males and 46% females. It was also found that both prepubertal 
and pubertal duration of diabetes appear to be relevant for the development of 
background retinopathy. However, with prepubertal onset of diabetes, the 
duration of time to the development of retinopathy is significantly shorter than 
with pubertal onset of diabetes [17]. In patients with an HbA1c level <7.5%, 
the median diabetes duration until retinopathy developed was 18.3 years 
compared to 15.5 years in patients with an HbA1c level >7.5% (defined as 
poor glycaemic control), thus demonstrating that poorer glycaemic control is 
associated with earlier onset of retinopathy [17]. A review by E.M. Kohner also 
suggests that improved glycaemic control can delay the onset and reduce the 
severity of diabetic retinopathy [19]. Good glycaemic control should therefore 
be the principal focus in all paediatric and adolescent patients irrespective of 
patient age or age of onset of diabetes [17].  
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Diabetic nephropathy is also a microvascular complication of concern. 
Paediatric and adolescent type 1 Diabetics have an increased risk of diabetic 
nephropathy which can eventually lead to renal failure. This can progress to 
end-stage renal failure which would eventually require dialysis and 
transplantation [20]. Microalbuminuria has been used worldwide as a 
preceding marker for the development of overt diabetic nephropathy [20, 21]. 
It is defined as a urine albumin to creatinine ratio (UAC) > 2mg/mmol in at 
least two of three consecutive early morning urine samples [21]. 
 
In the MIDAC (Microalbuminuria in Diabetic Adolescents and Children) study 
of 2000, it was found that 9.7% of patients between 10 and 20 years of age 
had microalbuminuria, placing them at risk of later developing diabetic 
nephropathy [21]. A study by Kiemans Raile et al (2007), which included 
children, adolescents and adults and was within 40 years of diabetes duration, 
demonstrated the prevalence of diabetic nephropathy to be 25.4% for 
persistent microalbuminuria but only <10% for macroalbuminuria (UAC ratio 
>35mg/mmol) or end-stage renal disease. However, this study defined 
microalbuminuria with a UAC ratio >2.5mg/mmol as per the American 
Diabetes Association guidelines [20]. The prevalence rate was found to be 
lower than that of various other studies done in Denmark, England and 
Western Australia with the most prominent difference being improved 
glycaemic control as demonstrated by lower HbA1c levels [20]. Overall, the 
prevalence of microalbuminuria in childhood increases with the age of the 
population under study (p<0.001) with risk factors including poor long-term 
(diabetes duration>1 year) glycaemic control, longer duration of diabetes and 
possibly hypertension [21, 22]. The mean HbA1c level was also found to be 
higher in patients with microalbuminuria than those with normal urinary 
albumin excretion (p=0.001). This strengthens the fact that improved 
glycaemic control would delay the development of diabetes-associated 
complications [21] and more specifically, microalbuminuria [22, 23]. 
 
A cohort study done by F. Mohsin et al (2005) and a study by E. Downie et al 
(2011), both in Australia, looked at trends in microvascular complications in 
adolescents with type 1 diabetes [15, 23].  With Mohsin’s study, three time 
periods were analysed. It was found that retinopathy, early elevation of 
albumin excretion rate and microalbuminuria, declined significantly over time. 
The prevalence of retinopathy declined from 49% to 24% (p<0.0001), early 
elevation of albumin excretion rate declined from 38% to 25% (p=0.022) and 
microalbuminuria declined from 7% to 3% (p=0.017). However, the 
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prevalence of peripheral nerve abnormalities, as measured by quantitative 
sensory tests (i.e. vibration and thermal threshold) increased from 12% to 
24% (p=0.0017) [15]. With E. Downie’s study, 4 time periods were analysed. 
There was also a reduction in the prevalence of retinopathy over time from 
53% to 12% (p<0.001) as well as microalbuminuria from 8% to 3% (p=0.006), 
whereas borderline elevation of albumin excretion rate declined initially from 
45% to 26% before reaching a plateau of 30% (p<0.001). The prevalence of 
peripheral neuropathy increased from 7% to 14% (p=0.016) [23]. 
 
A Rwandan study by S.L. Marshall et al (2013) demonstrated the rates of 
microalbuminuria, nephropathy and neuropathy to be 20.8%, 4.7% and 2.1% 
respectively with HbA1c being positive predictors for microalbuminuria. 
Clinical data and complication assessment was however incomplete and 
retinopathy was not investigated due to lack of diagnostic equipment [14]. A 
later study performed by S.L. Marshall et al in Rwanda in 2014 demonstrated 
the incidence of microalbuminuria and nephropathy to be 16.6% and 3.3% 
respectively however with the same concerns regarding incomplete data [24]. 
 
Dyslipidaemia is also associated with the development of diabetic 
nephropathy in children and adults with type 1 diabetes [20, 25] as well as 
with the development of macrovascular (cardiovascular) disease in high risk 
diabetics [26]. Raised LDL cholesterol and triglycerides appear to be 
independently associated with microalbuminuria [20]. A substantial proportion 
of young diabetic patients have abnormal serum lipids with prevalence in type 
2 diabetics being higher than in type 1 diabetics > 10 years of age. This 
SEARCH for Diabetes in Youth Study demonstrates that 20% of type 1 
diabetics >10 years of age have Total Serum Cholesterol (TSC) 
concentrations >5.7mmol/l [27]. Abnormal serum lipids were found in 73.5% of 
type 1 diabetic children in a study by I. Sylvester at the Muhimbili National 
Hospital in Dar es Salaam in 2012, with a raised LDL cholesterol of 29.6%, 
high TSC of 25.5%, low LDL cholesterol of 13.3% and high triglycerides of 
5.1%. Abnormal lipid profile was associated with worsening glycaemic control 
but this was not confirmed with statistical tests [26]. 
 
Limited joint mobility (LJM), also known as juvenile diabetic cheiroarthropathy, 
although not classified as a complication of diabetes, has been reported in 
many studies, occurring in type 1 diabetics [28, 29, 30, 31, 32]. LJM is 
described as a non-painful contracture of finger joints [29]. Prevalence varies 
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between studies from 26% to 65.1% and is dependent on the method used to 
evaluate this clinical feature [28, 29, 30, 31, 32], longer duration of diabetes 
[28, 29, 31, 32] and presence of microalbuminuria [29, 32] and retinopathy 
[29, 30, 32]. Qualitative methods involve assessment using the prayer 
manoeuvre [28, 29, 30, 31, 32], whereas quantitative methods measures the 
angles of maximal flexion and extension of the fifth and third 
metacarpophalangeal joints and wrist [28, 29]. 
 
In order to limit these complications and maintain adequate metabolic control 
in the type 1 diabetics, insulin therapy remains the mainstay of treatment. The 
basal bolus regimen (multiple injections/day) is now being considered to be 
the gold standard by most paediatric diabetologists [33]. This regimen aims to 
mimic the physiological insulin profile as seen in non-diabetics as well as to 
allow flexibility required by the lifestyle needs of diabetic children and is 
therefore the better treatment option compared to conventional insulin therapy 
(one or two injections/day) which is a compromise between convenience and 
the potential for achieving target plasma glucose levels. 
 
Metabolic control and early diagnosing of complications in type 1 diabetics 
could also be improved by implementing a multi-disciplinary approach 
involving a diabetic specialist, diabetic educator, dietician and social worker 
as per the ISPAD clinical practice consensus guidelines [7, 8]. 
 
A study by M. O’Hagan and J.N. Harvey investigated specifically, the 
influence of a DNE on glycaemic control over a period of 6 years. They found 
improved glycaemic control in centres where a DNE had been appointed from 
an HbA1c of 9.59 + 1.88% (mean + SD) to 8.72 +1.61% (mean + SD) 
(p<0.001). This improvement was not attributed to increased prescribed 
insulin dose as increased insulin dose was associated with poorer glycaemic 
control. DNEs were found to have a supportive and educational role with 
increased contact with patients and their families resulting in the greatest 
improvement in glycaemic control of children >10 years of age (p=0.047). This 
suggests that DNEs may have a positive influence on behavioural factors 
present in adolescence [34]. 
 
Statistically significant improved metabolic control (p<0.001) from 8.7+1.8% 
(mean + SD) to 8.1+1.5% (mean + SD), with a reduction in HbA1c of 0.038% 
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per year (95%CI 0.032-0.043%) was also documented in a study by J. 
Rosenbauer et al. This also suggests the improvement is as a result of the 
implementation of a multi-disciplinary diabetes team as well as increasing 
patient education [13]. 
 
A study done by F.J. Cowan et al at the University Hospital of Wales 
investigated outpatient clinic non-attendance rate, median hospital stay at 
diagnosis and admission rates, a year after implementation of a DNE. Clinic 
non-attendance decreased significantly from a median of 19% to 10% 
(p<0.001) in the paediatric clinic and from 38% to 23% (p<0.05) in the 
adolescent clinic, median hospital stay at diagnosis dropped from 5 days to 1 
day (p<0.001) and admission rates at diagnosis was reduced from 100% to 
41.7% [9].  
 
In a recent Tanzanian study by L.J. Mukama et al at the Kilimanjaro Christian 
Medical Centre (2013), HbA1c levels did not improve 6 months after the 
implementation of a diabetes management program, despite regular clinic 
attendance, diabetes education and insulin provision. Factors associated with 
worse glycaemic control included fewer clinic attendances, longer diabetes 
duration, larger insulin doses and male gender. Despite HbA1c levels not 
reaching statistical significance, there was a downward trend from 12.4% to 
11.2%. It is most likely that a longer period of study is needed to observe a 
statistically significant improvement in glycaemic control [5]. 
 
A DMT was introduced at TCH in August 2007. The team consisted of a newly 
appointed paediatric endocrinologist, a dietician, a social worker and the ward 
nursing staff. A dedicated DNE for paediatrics was only appointed by the 
university to work at TCH in August 2009, because the hospital management 
did not consider her post a priority at the time. This appointment was 
expected to improve metabolic control, education of patients and caregivers, 
clinic attendance and reduce hospital admissions as deduced from other 
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To determine the effectiveness of the diabetes management team and a DNE 
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To perform a study of the type 1 diabetic paediatric and adolescent patients 
attending the diabetic clinic at Tygerberg Children’s Hospital over 4 time 
periods: August 2004-July 2005 (Period 1); August 2007-July 2008 (Period 2); 
August 2009-July 2010 (Period 3); and September 2010-July 2011 (Period 4) 
to determine: 
1 glycaemic control; 
2 the admission rate for diabetic ketoacidosis (DKA), recurrent 
DKA and uncontrolled diabetes; 
3 length of hospital stay; 
4 clinic attendance rate; 
5 insulin dose/kg; 
6 % of patients on the intensive insulin regimen; and 
7 the prevalence of microvascular complications (nephropathy, 
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It was hypothesised that the introduction of a full DMT (which includes a DNE) 
for the care of children and adolescents with T1DM at TCH would 1) improve 
the glycaemic control (as measured by the HbA1c), 2) decrease the DKA and 
rDKA rates, 3) reduce  admission rates, 4) shorten the length of hospital stay, 
5) improve clinic attendance rate, 6) lead to a reduced dose of insulin per 
patient, 7) facilitate the use of an intensive insulin regimen, and 8) decrease 
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6.1 STUDY DESIGN 
 





Adolescent: Patients 13-17 years 11 
months of age. 
 
Glycaemic control is indicated by the: 
 HbA1c level:    <7.5%: good control 
7.5-8.4%: acceptable control 
>8.5%: poor control 
>14%: very poor control [8, 
13] 
 
Limited joint mobility (LJM): A complication of type 1 
diabetes mellitus, which is a 
cutaneous condition 
characterised by thickened 
skin of the hands and fingers, 
leading to flexion contractures 
which impairs joint mobility 
[35]. 
 
Microalbuminuria: Urine albumin to creatinine 
ratio (UAC) > 2mg/mmol in at 
least two of three consecutive 
early morning urine samples 
[21]. 
  
Recurrent DKA:     > 2 DKA episodes [36] 
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Time periods: 
 Period 1 (P1):    August 2004-July 2005 
 Period 2 (P2):    August 2007-July 2008 
 Period 3 (P3):    August 2009-July 2010 




T1DM children and adolescents attending the paediatric diabetes clinic at 
TCH. 
 
6.4 PATIENT INCLUSION AND EXCLUSION CRITERIA 
 
Patients were included if: 
a) they required insulin therapy after the neonatal period but before 
adolescence, irrespective of whether T1DM was confirmed on low serum C-
peptide levels and elevated anti-glutamic acid decarboxylase (GAD) /Islet 
Antigen 2 (IA2) antibodies or not; 
 b) they were managed during the following time periods: August 2004-July 
2005 (P1): before a diabetic management team was introduced, but a 
paediatric endocrinologist was on site; August 2007-July 2008 (P2): 
introduction of DMT after a period when no paediatric endocrinologist was 
available; August 2009-July 2010 (P3): introduction of a DNE; and September 
2010-July 2011 (P4): after substitution of the DNE. 
 
The following patients were excluded: known patients with type 2 diabetes, 
monogenic and secondary forms of diabetes. 
 
6.5 ETHICAL APPROVAL 
  
Ethics approval was applied for and obtained from the Committee for Human 
Research at the University of Stellenbosch. As it was a retrospective folder 
review, a waiver of Informed Consent was obtained from the Medical 
Superintendent of TCH. Confidentiality was maintained by assigning a case 
number to each patient. 
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The following data was captured: age, sex, age at diagnosis (in years and 
months), ethnicity, HbA1c (mean HbA1c’s at the end of each time period of all 
the patients occurring in that time period), lipid profiles [total serum cholesterol 
(TSC), high-density lipoprotein cholesterol (HDLC), low-density lipoprotein 
cholesterol (LDLC) and triglycerides (TG)], UAC ratio (mean UAC’s at the end 
of each time period of all the patients occurring in that time period), 
presence/absence of retinopathy, neuropathy and limited joint mobility, 
hospital admissions, reason for admission (i.e. diabetic ketoacidosis or 
uncontrolled diabetes), duration of hospital stay (in days), and number of clinic 
attendances/year. Data also included type of insulin (short/rapid or 
intermediate acting), number of insulin injections/day and insulin doses with a 
hospital/clinic visit (at the end of the time period). 
 
Various data sources were used to collect the data: Computerised diabetic 
register of current patients established by the DNE; the buffs of old and 
current patients kept at the clinic, patient folders which were accessed 
through the hospital records using ICD 10 codes for all diabetics (Type 1, 
Type 2 and other) from 0-18 years of age, and laboratory data stored by the 
National Health Laboratory Service (NHLS). 
 
The data was checked for missing and suspicious values. For patients where 
day of the month of diagnosis was unknown, the 15th of that month was used 
(36 patients). For patients where the month of the year of diagnosis was 
unknown, the 30th June was used (2 patients). 
 
HbA1c EDTA specimens were initially analysed in the laboratory until 2009. 
The method used for measuring HbA1c was standardised according to the 
National Glucose Standardisation Program (NGSP) and is the same method 
used by the DCCT. From 2009, HbA1c capillary specimens were analysed 
using a point of care device, the Siemens DCA Vantage Analyzer. The 2 
methods were compared by the NHLS in 35 subjects. The within assay 
coefficient of variation (CV) was 1.2% for the low control HbA1c of 5.1% and 
4.3% for the high control HbA1c of 12.9%, whereas the between assay CV 
was 2.4% for the low control and 3.2% for the high control. Both assays were 
well within the acceptable CV of 5%. The precision quality requirements for 
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the analyzer were within the recommended targets of 14% and 18% 
(unpublished personal communication by Dr M.A. Rensburg, Chemical 
Pathologist, Tygerberg Hospital). 
 
6.7 STATISTICAL ANALYSIS 
 
The data was analysed by the Statistical Department of The University of 
Stellenbosch, using Statistica 11 (2013). Statistical analysis was performed on 
the total patient group as well as on the patient group who had data in all 4 
time periods.  
 
A 5% significance level was applied throughout. Friedman’s ANOVA was 
used to compare changes in a specific variable over time (patient group who 
had data in all 4 time periods). Results were obtained for several 
combinations of the 4 different periods and in each case only those patients 
with available data at each of the periods in the respective combination for a 
particular variable were included. Box and whisker plots, representing the 
mean, standard error (SE) and 95% confidence intervals were used to 
describe the distribution of each parameter within a specific period. P-values 
were also generated for the numerical data. 
 
With regards to the total patient group, box and whisker plots representing the 
mean, standard error (SE) and 95% confidence intervals were also used to 
describe the distribution of each parameter within a specific period. Median 
values were also generated for the numerical data. 
 
Pearson’s chi-squared test was used to compare differences between insulin 
categories and a combination of gender and age categories. 
 
Generalised Estimating Equations (GEE) were used to determine whether 
there was a significant change over the periods in LJM. 
 
 
 6.8 LIMITATIONS 
  
Some of the limitations are those typical of a retrospective study i.e. 1) 
inadequate documentation of clinical and biochemical data by the attending 
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medical doctors, 2) lost or misplaced clinical records, and 3) microfilmed data 
in the older diabetic patients that were of poor quality. The remaining 
limitations are unique to this particular study. 
 
All patients did not have confirmatory testing of their UAC ratio as per the 
recommended guidelines and transient microalbuminuria could not be 
distinguished from persistent microalbuminuria. Also, limited joint mobility was 
not assessed during Period 1. 
 
Insulin resistance which is associated with obesity or an increasing weight 
could lead to Type 2 diabetes. Insulin insufficiency results in Type 1 diabetes. 
If a T1DM child is obese, insulin resistance to the administered insulin may 
also occur [37]. Data regarding BMI was however not collected. This would 
have been problematic if the patients’ BMI increased over time, because of a 
high BMI being associated with insulin resistance. As a result, the HbA1c 
would have been expected to rise. The opposite was actually the case – the 
HbA1c decreased over time. One can therefore only assume that weight 
increase was not a significant confounder with regards to the results obtained. 
 
When analysing HbA1c levels, patients in various stages of diabetes were 
included in period 1, resulting in a heterogenous group of patients.  
Depending on the criteria used, 2-8 patients were probably in the honeymoon 
phase (although none of these had an HbA1c < 7%). This could have 
artificially reduced the mean HbA1c in period 1, making a direct comparison of 
the various periods more difficult.  
 
Puberty data was not captured when analysing HbA1c levels. However, using 
age criteria to define puberty (boys >12 years and girls > 11 years of age), it 
was found that 18 of 22 patients were in puberty in period 4 also resulting in a 
heterogenous group of patients. The expected result would be an inflated 
HbA1c, with poorer control and more complications due to associated insulin 
resistance, as well as insulin omission during this rebellious phase of life.  
 
Children grow and develop over time. At 18 years of life, patients were being 
referred to the adult service for further management. Similarly, new patients 
were being diagnosed during all periods. The patient population was therefore 
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not static. Hence, most analysis had to be limited to those patients observed 
during all 4 time periods. As a consequence, sample size was reduced and 
variable for the different parameters that were assessed.  Irrespective of this, 
statistically significant changes could still be identified.    
 
Ideally, a longer duration of study is needed after employment of any DNE, as 
considerable time is needed for training and gaining experience. Furthermore, 
any educational intervention in any particular chronic disease will take 
considerable time to be effective. This is particularly true for admission rates 
and HbA1c levels. Unfortunately, due to unforeseen circumstances, a second 
DNE had to be employed during the study period. Under ideal conditions, the 
effect of a single DNE should have been assessed after 2 years, as one 
cannot assume that the 2 DNEs would perform exactly the same. 
 
About 25% of patients reside in rural areas. Because of the long distances to 
the academic hospitals, patients from these areas presenting in DKA may 
have preferentially been treated at a district hospital without being transferred 
to the tertiary centre. Teenagers in DKA on the other hand may present to the 
adult emergency unit and be managed further in the adult diabetes service. 
The DKA and rDKA rates may therefore actually be higher than documented 
in this study. Bias towards any particular time period is not to be expected, 
because the number of patients in DKA, not presenting to the Paediatric 
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A total of 190 paediatric and adolescent patients with type 1 diabetes were 
included over the 4 time periods. However, within the various time periods, 
new patients were diagnosed, patients were lost to follow-up and some 
patients were transferred to the adult diabetic clinic. Also, many patients were 
seen in some time periods, but not in others. These factors therefore resulted 
in varying patient numbers per time period but with a cumulative increase in 
the number of patients as time progressed. Period 1 comprised a total of 77 
patients on treatment. At this stage 113 patients were yet undiagnosed, 
adding up to the total of 190.  Period 2 comprised of 112 patients on 
treatment, 57 undiagnosed patients, 8 patient transfers and 13 patients lost to 
follow-up (190 patients). Period 3 comprised of 135 patients, 19 undiagnosed 
patients, 9 patient transfers and 27 patients lost to follow-up (190 patients). 
Period 4 comprised of 139 patients, 16 adult clinic transfers and 35 patients 
who were lost to follow-up (190 patients). Also, due to missing data, the 
number of values/measurements is not consistent across all variables. 
 
7.1 PATIENT CHARACTERISTICS 
 
The patient characteristics are shown in table 1. 
 
There was a female predominance of 65.3% compared to males. The highest 
proportion of patients with type 1 diabetes was seen in the age category of 
pre-pubertal girls (46.3%). 
 
With regards to the types of insulin therapy, the Human soluble insulin and 
NPH insulin combination were more commonly used than the insulin 
analogues as these are more freely available in the public sector. 
The following was missing for one patient: age at diagnosis, age category 
based on sex and types of insulin therapy. 
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Table 1: Patient characteristics (all patients) 
Characteristic  n (%) 
Age at diagnosis (years)1 <2 15 (8) 
 2-10 88 (46.3)  
 > 10  86 (45)  
Age category based on gender 
(years)2 
Boys<12 49 (25.8) 
 Boys >12 17 (8.9) 
 Girls<11 88 (46.3) 
 Girls>11 35 (18.4) 
Sex Male  66 (34.7)  
 Female  124 (65.3)  
Ethnicity Coloured  143 (75.3)  
 Black  25 (13.2)  
 White  22 (11.6)  
Types of Insulin therapy3:  
  Short-acting  
Human Soluble 
Insulin  
164 (86.8)  
 Rapid Acting Insulin 
Analogue  
25 (13.2)  
  Intermediate-acting  NPH Insulin  181 (95.3)  
 Long Acting Insulin 
Analogue  
9 (4.7)  
                                                                
1 Age data missing in 1 patient 
2 Age category based on sex data missing in 1 patient 
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7.2 GLYCAEMIC CONTROL 
 
Twenty two patients had HbA1C data in all 4 time periods (figure 1). The 
mean HbA1c increased from 9% (95% CI 7.85-10.15) in period 1 to 10.9% 
(95% CI 9.6-12.2) in period 2, and decreased to 9.25% (95% CI 8.75-9.75) in 
period 4 (p=0.01818). 
 
 
 Figure 1: HbA1c levels per time period (for patients with HbA1c in all 4 
time periods) 
 
Table 2 shows the characteristics of the patients with HbA1c levels captured 
in all 4 time periods. The age at diagnosis, age category based on gender, 
ethnicity and types of insulin therapy compares well with the total patient 
group. With regards to gender, there is an equal distribution of males and 
females compared to a female predominance in the total patient group. 
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Table 2: Patient characteristics of patients with HbA1c levels captured in 
all 4 time periods 
Characteristic  n (%) 
Age at diagnosis (years) <2 3 (13.64) 
 2-10 14 (63.6) 
 > 10  5 (22.73)  
Age category based on gender (years) Boys<12 11 (50) 
 Boys >12 0 
 Girls<11 11 (50) 
 Girls>11 0 
Sex Male  11 (50)  
 Female  11 (50)  
Ethnicity Coloured  18 (81.82)  
 Black  2 (9.09)  
 White  2 (9.09)  
Types of Insulin therapy:  
  Short-acting  
Human Soluble 
Insulin  
21 (95.45)  
 Rapid Acting Insulin 
Analogue  
1 (4.55)  
  Intermediate-acting  NPH Insulin  21 (95.45)  
 Long Acting Insulin 
Analogue  
1 (4.55)  
 
As can be seen from table 3, the proportion of patients with good and 
acceptable glycaemic control initially decreased, but then increased again in 
period 4. The percentage of patients with very poor control doubled from 
period 1 to period 2, but declined again in periods 3 and 4 to less than half of 
the original proportion. Period 1 comprised a total of 64 patients with data and 
13 patients with missing data (77 patients). Period 2 comprised a total of 93 
patients with data and 19 patients with missing data (112 patients). Period 3 
comprised a total of 101 patients with data and 34 patients with missing data 
(135 patients). Lastly period 4 comprised a total of 122 patients with data and 
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Table 3: Level of glycaemic control per time period (all patients) 









      n (%) n (%) n (%) n (%) 
HbA1c4 
Good 
control5 12 (18.8) 7 (7.5) 4 (4) 13 (10.7) 
  
Acceptable 
control6 12 (18.8) 3 (3.2) 11 (10.9) 16 (13.1) 
  Poor control7 35 (54.7) 69 (74.2) 83 (82.2) 89 (73) 
  
Very poor 
control8 5 (7.8) 14 (15) 3 (3) 4 (3.3) 
                                                                
4 Patients with missing data not included 
5 Good control: <7.5% 
6 Acceptable control: 7.5-8.4% 
7 Poor control: >8.5% 
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7.3 DKA  
The DKA rate showed improvement as time progressed, whereas the rDKA 
rate dropped drastically from period 1 to period 2 and thereafter remained 
static (table 4 and 5).In all time periods more girls presented with rDKA than 
boys. 
 
Table 4: Prevalence of DKA per time period (all patients) 
  
DKA rate  
(per 100 patient  years) 
Aug 2004-July 2005 32.5 
Aug 2007-July 2008 27.7 
Aug 2009-July 2010 26 
Sept 2010-July 2011 23.5 
  








n (%) n (%)2 
 
n (%) 
Aug 2004-July 2005 
 
6 (18.8) 2 (33.3) 
 
4 (66.7) 
Aug 2007-July 2008 
 
5 (10) 2 (40) 
 
3 (60) 
Aug 2009-July 2010 
 
6 (10.3) 1 (16.7) 
 
5 (83.3) 
Sept 2010-July 2011 
 
5 (9.6) 2 (40) 
 
3 (60) 
                                                                








Stellenbosch University  https://scholar.sun.ac.za
23 | P a g e  
 
7.4 NUMBER OF ADMISSIONS, LENGTH OF HOSPITAL 
STAY AND NUMBER OF CLINIC ATTENDANCES 
 
Table 6: Number of admissions, length of hospital stay and number of 














n (%) n (%) n (%) n (%) 
 
Number of 
admissions10 0 31(49.2) 50(50) 70(54.7) 85(61.6) 
 
 
1 21(33.3) 32(32) 48(37.5) 42(30.4) 
 
 
2 9(14.3) 16(16) 8(6.3) 8(5.8) 
 
 
>2 2(3.2) 2(2) 2(1.6) 3(2.2) 
 
Length of stay 
(days)11 < 7 10(33.3) 6(12) 11(19) 10(18.9) 
 
 
7-14 8(26.7) 14(28) 14(24.1) 18(34) 
 
 
14-30 12(40) 15(30) 23(39.7) 17(32) 
 
 




attendances12 >4 48(67.6) 55(51.9) 88(67.2) 77(55.8) 
 
 <4 23(32.4) 51(48.1) 43(32.8) 61(44.2) 
 
                                                                
10 Patients with missing data not included 
11 Patients with missing data not included 
12 Patients with missing data not included 
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Number of admissions 
The total numbers of patients with > 1 hospital admission were 32/77 (the 
denominator indicates the total no of patients in the period) for period 1, 
50/112 for period 2, 58/135 for period 3, and 53/139 for period 4. There were 
missing data for 14 patients in period 1, 12 patients in period 2, 7 patients in 
period 3 and 1 patient in period 4. The number of all admissions (for both DKA 
and poor glycaemic control) decreased during time periods 3 and 4 (figure 2). 
The proportion of patients who had no admissions increased progressively 
from 49.2% in period 1 to 61.6 % in period 4, while the proportion with 2 
admissions decreased from 14.3% in period 1 to 5.8 % in period 4 (table 6). 
For patients captured in all 4 time periods, the number of admissions 
decreased with each time period (figure 3). This was found to be highly 
statistically significant (p=0.0127).  
 
 
 Figure 2: Number of admissions per time period (all patients) 
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Figure 3: Number of admissions per time period (patients captured in all 
4 time periods) 
 
Length of hospital stay 
As can be seen from table 6, period 1 is characterised by shorter hospital 
stays.  From period 2 hospital stays are longer. The proportion of patients 
staying longer than 30 days subsequently decreased again from 30% in 
period 2 to 15.1 % in period 4. For those patients documented to have > 1 
number of admissions, there was missing data for only 2 patients in period 1. 
 
Number of clinic attendances 
As can be seen in figure 4, for patients captured in all 4 time periods, the 
mean number of clinic attendances were variable at 4.3 (95% CI 3.76-4.9) in 
period 1; 3.9 (95% CI 3.44-4.34) in period 2; 4.9 (95% CI 4.4-5.4) in period 3 
and 3.8 (95%CI 3.24-4.44) in period 4 (p=0.00859). A similar pattern was 
observed for all patients (table 6). There were missing data for 6/77 patients in 
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period 1, 6/112 patients in period 2, 4/135 patients in period 3 and 1/139 
patients in period 4. 
 
 
Figure 4: Number of clinic attendances per time period (patients 
captured in all 4 time periods) 
 
7.5 INSULIN THERAPY 
  
 Number of insulin injections per day 
The number of insulin injections per day increased over time from 2.93 (95% 
CI 2.85-3.01) in period 1 to 3.14 (95% CI 3.06-3.23) in period 4 (figure 5). 
When comparing the 35 patients with data in all 4 time periods for number of 
insulin injection per day (figure 6), the mean number of insulin injections 
increased from 2.97 in period 1 to 3.11 in period 4 (p=0.0015). For the total 
patient group (figure 5); during period 1, 7 patients (9.7%) were on 2 insulin 
injections/day, 63 patients (87.5%) were on the modified conventional 
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regimen of 3 insulin injections/day and 2 patients (2.8%) were on the basal 
bolus regimen of >4 insulin injections/day. During period 4, the number of 
patients on 2 insulin injections/day decreased to 1, 112 patients (81.8%) were 
on the modified conventional regimen and the number of patients on the basal 
bolus regimen increased to 24 patients (17.5%). 5 patients had missing data 
in period 1 and 2 patients had missing data in period 4. 
 
 
 Figure 5: Number of insulin injections/day per time period (all patients) 
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Figure 6: Number of insulin injections/day per time period (patients 
captured in all 4 time periods) 
 
Insulin dose per day 
As can be seen in figure 7, the mean insulin dose for all patients in period 1 
was significantly higher than in the other 2 groups i.e. 1.19 u/kg/day (95%CI 
1.077-1.305) versus  0.88 u/kg/day (95%CI 0.818-0.933) in period 2, 0.94 
(95% CI 0.878-1.003) in period 3 and 0.93 (95%CI 0.867-0.9984) in period 4. 
A similar trend was seen when analysing patients seen in all 4 time periods 
(figure 8), but significance was lost (p=0.53) with overlap of the CIs in all time 
periods. The mean insulin dose is still the lowest in period 2. The percentage 
of patients requiring an insulin dose of >2 u/kg/d (indicating insulin resistance) 
varied between 0 (period 2) and a maximum of 2.9% (period 1). There were 
missing data for 7/77 patients in period 1, 8/112 patients in period 2, 6/135 
patients in period 3 and 1/139 patients in period 4. 
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 Figure 7: Insulin dose/day per time period (all patients) 
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Table 7 gives an overview of the prevalence of complications during the 
various time periods. These could not be compared statistically, because the 
number of patients with documented complications in the various periods was 
small. The presence of retinopathy, all non-proliferative, was only documented 
in the last 2 time periods. One patient’s type of retinopathy was unknown. 
Only 1 case of neuropathy was diagnosed in period 4. The UAC ratio was 
documented fairly consistently over all 4 time periods. It varied little over time 
(figure 9). 
 
During the first time period, LJM was either not present (which is less likely) or 
not assessed (table 7). Similarly, only 1 patient had a documented lipogram in 
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period 1. Hence it was not possible to include the lipid profiles for this period 
in any statistical analysis. TSC and LDLC followed a similar pattern (figures 
10 and 11), both being lower in periods 3 and 4 compared to period 2, but 
LDLC being significantly lower (figure11).  There was a trend for HDLC to be 
lower in period 4 (figure 12).  The TG levels were similar throughout all 3 time 
periods (figure 13). The majority of patients had desirable/ideal levels of TSC, 
TG, LDLC and HDLC except during period 2 when only 15.8 % of patients 
had an ideal LDLC level (table 8). The highest proportion of ideal HDLC levels 
of 68.2% was seen in period 2 (table 8).   
 
Table 7: Complications 









    n (%) n (%) n (%) n (%) 
Microalbuminuria13 8/2214 (36.4) 7/25 (28) 30/65 (46.2) 18/67 (26.9) 
Retinopathy 0/25 0/34 6/45 (13.3) 6/58 (10.3) 
Neuropathy 0/26 0/39 0/79 1/88 (1.1) 
Limited Joint Mobility Not assessed 13/50 (26) 36/89 (40.4) 42/98 (42.9) 
                                                                
13 Microalbuminuria: Urine albumin to creatinine ratio > 2mg/mmol in at least  
two of three consecutive early morning urine samples [21]. 
14 Denominators represent the total number of patients assessed for complications in the 
specific time periods. 
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 Figure 9: Urine albumin/creatinine ratio per time period (all patients) 
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 Figure 11: LDL Cholesterol per time period (all patients) 
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Stellenbosch University  https://scholar.sun.ac.za
37 | P a g e  
 
Table 8: Lipid profiles: Proportion of patients with ideal or poor levels15 









    n (%) n (%) n (%) n (%) 
TSC16 High 6 (17.1) 4 (13.3) 10 (15.9) 11 (17.2) 
  Borderline high 3 (8.6) 10 (33.3) 6 (9.5) 6 (9.4) 
  Desirable 26 (74.3) 16 (53.3) 47 (74.6) 47 (73.4) 
LDLC17 Very high 0 1 (5.3) 1 (1.6) 1 (2.4) 
  High 1 3 (15.8) 4 (6.6) 4 (9.5) 
  Borderline high 0 7 (36.8) 7 (11.5) 7 (16.7) 
 
Near ideal 0 5 (26.3) 13 (21.3) 11 (26.2) 
 
Ideal 0 3 (15.8) 36 (59) 19 (45.2) 
HDLC18 Poor 0 1 (5.3) 12 (19) 10 (23.3) 
 
Better 0 6 (31.6) 8 (12.7) 10 (23.3) 
 
Best 1 (1) 12 (63.1) 43 (68.2) 23 (53.5) 
TG19 High 0 0 4 (6.3) 5 (44) 
  Borderline high 1 3 (15.8) 3 (4.7) 3 (6.8) 
  Desirable 0 16 (84.2) 57 (89) 36 (81.8) 
                                                                
15 Patients with missing data are not included and certain patients were seen in some time 
periods, but not in others. 
16 TSC: High: >6.2mmol/l; Borderline high: 5.2-6.2mmol/l; Desirable: <5.2mmol/l 
17 LDLC: Very high: >4.9mmol/l; High: 4.1-4.9mmol/l; Borderline high: 3.4-4.1mmol/l; Near ideal:    
2.6-3.3mmol/l; Ideal: <2.6mmol/l 
18 HDLC: Poor: <1mmol/l (men); <1.3mmol/l (women); Better: 1-1.3mmol/l (men); 1.3-1.5mmol/l 
(women); Best: >1mmol/l 
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8.1 GLYCAEMIC CONTROL 
 
The HbA1c levels initially increased from period 1 to period 2 (figure 1). The 
increased HbA1c levels during period 2 (when a DMT was introduced), could 
be explained by the fact that there was no specialist for 4 ½ months and only 
a part-time specialist for another 3 ½ months prior to period 2 in 2006. The 
paediatric diabetic service during that time was therefore managed by 
inexperienced staff with limited training in diabetes care. The mean HbA1c 
levels then gradually dropped over periods’ 3 and 4 with narrowing of the CIs, 
demonstrating tighter glycaemic control after the appointment of the DNEs 
(less variation with fewer outliers). In addition institutionalisation of certain 
patients for lengthy periods for social and psychological issues may have 
contributed to better control.  HbA1c levels corrected to previous levels 2 
years after a DNE was appointed. Considering that most of these patients [10 
of the 11 girls (90.9%) and 7 of the 11 boys (63.6%)] were in the difficult 
adolescent phase with co-existing insulin resistance, the better glycaemic 
control with far less variation is a remarkable achievement. The similar HbA1c 
in period 1could be explained by the fact that of the total of 22 patients, 2 
patients required daily insulin doses < 0.5U/kg, and 8 patients were treated for 
less than 18 months, therefore both groups presumed to be in the honeymoon 
phase. One would however have expected the patients in the honeymoon 
phase to have an HbA1c< 7% which these patients did not. Nevertheless, 
these patients were captured in the relatively early stage of their disease 
where one would also expect a lower HbA1c. The CI was wider than in period 
4, indicating that a few patients in period 1 were definitely poorer controlled 
than in period 4. One can only assume that the impact of the DNE and the 
DMT on metabolic control would be even greater as time progresses. 
However, it would be more difficult to bring about a further change in HbA1c 
the closer one approaches the target level of 7.5%. 
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Although there was significant improvement in HbA1c over time, only 18.8% 
of patients in period 1 and 10.7% of patients in period 4 (table 3) achieved 
HbA1c levels <7.5%, which is considered good control as per the 
recommended ISPAD guidelines [7, 8, 13]. Even International studies 
revealed that the recommended HbA1c level is seldom reached, due to 
numerous factors including patient-related and/or treatment-related factors 
(see below). Results of a study done by E.-M.Gerstl et al in 2008 in Germany 
and Austria found the mean HbA1c level to be 7.8% which is still slightly 
higher than the recommended level as per the ISPAD guidelines(2000) but 
lower than that of various other studies including the Hvidore study (8.3%). 
The mean HbA1c level of 9.7 (figure 1) achieved in our clinic overall does 
however compare to studies from Denmark (9.1%) and France (9.0%) [2]. 
 
Recent studies performed in African countries also demonstrated poorer 
glycaemic control in a high percentage of patients [5, 14, 24]. A study done by 
L.J Mukama et al in Tanzania in 2013 showed that only 5% of children and 
adolescents aged 3-19 years had HbA1c levels of 7.5%, with 44% of patients 
having HbA1c levels >12.5%. Their level of good glycaemic control was found 
to be much lower compared to our study. 36% of their patients reported 
omission of insulin. Longer diabetes duration and a higher insulin dose/kg 
were associated with increased HbA1c levels. This was found despite the 
appointment of 2 paediatric endocrinologists, regular clinic attendance, 
diabetes education, provision of glucose testing materials and provision of 
insulin. However, there were many limiting factors which could explain the 
poor HbA1c levels, including poor infrastructure, no home refrigeration for 
insulin storage, short period of study (6 months) and glucose testing only once 
per week. Mean Hba1c levels however improved slightly from 12.4% to 11.2% 
over 6 months; although not statistically significant [5], and still higher than our 
mean HbA1c of 9.7%. Results of a study performed in Rwanda in 2012 in 
children, adolescents and adults aged <26 years, demonstrated mean HbA1c 
levels of 11.2+2.7% [14, 24]. With a follow-up study, Hba1c levels were 
assessed at 1 year and 2 year follow-up visits, where HbA1c was found to be 
10.2+2.6% and 9.8+2.6% respectively. This improvement was attributed to 
the establishment of regular diabetic care, HbA1c testing and increased 
patient education [24] and compares well to our mean HbA1c of 9.7%. 
 
The SEARCH for Diabetes in Youth study by R.A. Bell et al in 2009, 
demonstrated a higher prevalence of aHbA1c level of >9.5% in children > 15 
years (21.5%), compared to the younger age groups (3.4-11.2%) [39]. The 
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study by E.-M. Gerstl et al mentioned above also demonstrates an increase in 
HbA1c levels with age especially in the adolescent population. There is also a 
significant association of poorer glycaemic control in females compared to 
males due to the known differences in glucose metabolism. The increased 
HbA1c levels in adolescents are due to the lower insulin sensitivity and higher 
insulin clearance compared to younger children, associated with the growth 
hormone concentration. Also, because of behavioural changes during 
puberty, there is an increased risk of non-compliance to diabetic treatment, 
resulting in poorer glycaemic control [2]. In our study, there were roughly six 
years between period 1 and period 4. Contrary to expectations, a similar 
increase in HbA1c over time was not seen in our patients (figure 1). This 




The DKA rate showed improvement over time while the rDKA rate dropped 
drastically after period 1, but then remained static (tables 4 and 5). Credit 
should be given to the DMT including the DNEs. Longer hospitalisation of 
patients (table 6) to address social and behavioural issues would have 
contributed to the success. Factors outside the control of the DMT, e.g. social 
and psychological issues, could account for the lack of a further drop in the 
rDKA rate. In all time periods, more girls presented with rDKA than boys, 
presumably because emotional factors have a greater impact in females than 
in males. Girls also more frequently try to escape dangerous situations, such 
as sexual, physical or emotional abuse and therefore omit insulin to 
precipitate an episode of DKA. Similar observations were made by M. Fritsch 
et al [36], E. Bismuth et al [40] and A. Rewers et al [41], who cited female 
gender [36, 40, 41], associated psychiatric disorder [40, 41], underinsurance 
[40, 41] and a migrational background in patients [36] as associated factors. 
In the current study, there are limitations with regards to the DKA and rDKA 
rates. As previously explained, all DKAs may not have been documented 
because patients residing in rural areas may have been managed at rural 
hospitals because of the long travel time and minimal resources available for 
transport to tertiary hospitals. Teenagers may have also presented to the 
adult unit to be managed without redirection to the paediatric and adolescent 
diabetic unit at TCH. 
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Our DKA rate is appallingly high (23.5/100 patient years) compared to other 
studies. The DKA rate was found to be 7.5/100 patient years by the DCCT in 
adolescent patients [37]; 8/100 patient years in a Denver study by A Rewers 
et al (2002) in both children and adolescents [41]; 6.3/100 patient years in a 
German and Austrian study by M Fritsh and J Rosenbauer et al (2011) in both 
children and adolescents [36]; and 14.8% in a Tanzanian study by L.J. 
Mukama and A Nyindo et al (2013) in children and adolescents 3-19 years of 
age. DKA risk in the Tanzanian study was associated with insulin omission 
(p<0.05), higher HbA1c levels, higher prescribed insulin dose and as with 
other studies, adolescent age and female gender. The DKA rate in the 
Tanzanian study is lower than in our study and has been attributed to the 
greater availability of insulin during the study’s 6 month period [5]. Even the 
rDKA rate in our study is unacceptably high (9.6% in period 4). In Rewers’s 
study, the incidence was only 4.9% (61/1243) with 55.7% (34/61) being 
female (p=0.03) [41]. The incidence in M. Fritsch’s study was even as low as 
1% [36].  
 
8.3 NUMBER OF ADMISSIONS, LENGTH OF HOSPITAL 
STAY AND NUMBER OF CLINIC ATTENDANCES 
 
Number of admissions 
The study demonstrates that there was a steady decline in the number of 
admissions. This was true for the whole patient population, but even more 
pronounced for patients being followed through all 4 periods (figures 2 and 3). 
For the latter group this was highly statistically significant (p=0.00127), with no 
overlap of confidence intervals of periods 1 and 4 (95% CI 0.46-1.12 and 
0.02-0.34 respectively). The number of admissions dropped by about 25 % 
(from a mean of 0.7 to 0.5 admissions/period) for the whole patient population 
(figure 2) and by 75 % (from a mean of 0.8 to 0.2 admissions/period) for 
patients being followed through all periods (figure 3). This attests to the 
effectiveness of the full DMT and constitutes a cost saving for the hospital. It 
mirrors the change seen in the HbA1c. A study done by F.J. Cowan et al at 
the University Hospital of Wales, also demonstrated a reduction in admission 
rates from 100% before implementation of a DNE to 41.7% in the year after 
implementation of the DNE [9]. 
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Length of hospital stay 
There seems to be a trend for keeping diabetic children in hospital for a 
shorter duration and providing most of the care on an outpatient basis. For 
example, the length of hospital stay in the newly diagnosed type 1 diabetics in 
F.J. Cowan’s study was reduced, from a median hospital stay at diagnosis of 
5 days to 1 day, 1 year after implementation of a DNE [9]. This is however 
only possible if the service provided is of a high standard, community based, 
and social circumstances are favourable. Our patient population however has 
to rely on hospital services far more frequently, because 25% reside in rural 
areas, do not have access to transport and have poor financial circumstances. 
Hence regular visits to the clinic for training are impractical. DNEs are also not 
available in the periphery. Length of admission in our unit is therefore 
generally longer than in other units.  
 
Compared to period 1, hospital stay in our patient population was longer 
during periods 2-4 for several reasons. Firstly, patients were hospitalised for 
longer periods in an attempt to improve glycaemic control by facilitating 
training of all caregivers involved in the care of each respective child (who 
often had to come from far). Secondly, patients from unstable home 
environments often had to await alternative placement. Others had to rely on 
hospital transport as they resided in rural areas, did not have the financial 
means and could not reach home otherwise. Despite this, the number of 
patients hospitalised for > 30 days decreased progressively, presumably 




Number of clinic attendances  
Most patients attended the diabetes clinic approximately 4 times a year 
(figure4). This conforms to the recommended minimum annual number of 
clinic attendances. Periods 2 and 3however differs significantly from each 
other. The mean clinic attendance/period was 3.9 (95% CI 3.44-4.34) in 
period 2 and 4.9 (95% CI 4.4-5.4) in period 3. This constitutes a 25% increase 
in attendance rates between periods. Clinic attendance in period 2 is the 
worst of all, presumably because it immediately follows the 4 ½ month period 
where inadequately trained medical officers were responsible for the care of 
patients. It corresponds to the period where the HbA1c was the highest (figure 
1), indicating suboptimal care. Once tighter control was achieved, clinic 
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attendance could be allowed to drop in period 4 (figure 4) without a 
deterioration of HbA1c levels. Glycaemic control in fact continued to improve 
(figure 1). 
 
The non-attendance rate at the outpatient clinic documented by F.J. Cowan et 
al at the University Hospital of Wales was also significantly reduced from 19% 
to 10% in the children’s clinic (<14 years of age) and from 38% to 23% in the 
adolescent clinic (>14 years of age), 1 year after implementation of a DNE [9]. 
Although similar, the findings of our study are not quite comparable to the 
study above, because we analysed attendance rather than non-attendance 
rate.  
 
 8.4 INSULIN THERAPY 
  
Number of insulin injections per day 
Both the DCCT and its follow-up study, Epidemiology of Diabetes 
Interventions and Complications (EDIC) trial, confirms that intensified insulin 
therapy (> 3 insulin injections/day or continuous insulin pump therapy) in type 
1 diabetic paediatric patients, improve long-term glycaemic control compared 
to conventional insulin therapy (1-2 insulin injections/day) and therefore 
reduce the incidence of complications as well as delay progression of existing 
complications [42, 43, 44]. The DCCT demonstrated a mean HbA1c level at 
the end of their 10 year study period of 7.2% with intensive insulin therapy 
versus a mean HbA1c level of 9.1% in the patients treated with conventional 
insulin therapy in their study population of both adults and adolescents. With 
the follow up study Epidemiology of Diabetes Interventions and Complications 
Study (EDIC), HbA1c levels were found to be 8% in both intensive insulin 
therapy and conventional insulin therapy groups, 18 years after completion of 
the DCCT study [43]. 
 
Our study did not compare the effect of intensive insulin therapy versus 
conventional insulin therapy on glycaemic control. With time however, there 
was a significant increase in the number of patients receiving intensive insulin 
therapy (basal bolus regimen). The dedicated DNE could facilitate such a 
change, as this time and labour intensive regimen requires considerably more 
education and counselling. 
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Many of the patients in our study population were on the modified 
conventional insulin regimen (3 insulin injections/day) throughout the 4 time 
periods as chosen by the patients and parents themselves. This is due to the 
fact that many of our patients and parents lack the capacity or financial 
resources to comply with the basal bolus regimen. Patients initially on the 
conventional regimen (2 insulin injections/day) were switched to the modified 
conventional regimen, possibly contributing to the overall better glycaemic 
control. 
 
Insulin dose per day 
The highly significant difference in daily insulin dose between period 1 and 
periods 2-4 can probably be attributed to a different management approach by 
the two different endocrinologists employed by the hospital (figure 7).  The 
HbA1C levels achieved in periods 1 and 4 were similar, implying that there 




The assessment of complications is initiated 5 years after onset of T1DM in 
pre-pubertal patients versus 2 years in pubertal patients. As an aide memoire 




The prevalence of microalbuminuria for all patients was variable for the 
various time periods with period 4 having the lowest prevalence i.e. 26.9% 
(table 7). No statistical test could be done for the whole population as it was 
not a stable population i.e. patients were entering and exiting the cohort in 
each period. Following the same patients throughout all 4 time periods 
however, revealed a similar mean UAC ratio in all periods. For prevalence of 
microalbuminuria to therefore truly change, a longer period of observation 
after intervention is probably needed. 
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A study by Kiemans Raile et al published in 2007, demonstrated the 
prevalence of persistent microalbuminuria to be 25.4% which is similar to our 
findings. However, this study included children, adolescents and adults and 
was within 40 years of diabetes duration [20]. In the MIDAC study of 2000 
performed in paediatric diabetic outpatient clinics in the United Kingdom and 
Republic of Ireland, only 9.7% of 10-20 year old patients had 
microalbuminuria [21]. The Rwandan study by S.L. Marshall et al in 2013, had 
microalbuminuria and nephropathy rates of 20.8% and 4.7% respectively, 
which is also quite similar to our rates. However, not all patients in the 
Rwandan study were screened for complications because of logistical 
problems, so the rates may actually be higher. Patients with microalbuminuria 
compared to those without, had a younger mean age at diagnosis (17.9+4.2 
years vs. 18.9+4.3%, p=0.01) and longer duration of diabetes (5.0+3.1 years 
vs. 3.5+3.2 years, p=0.02). HbA1c was not found to be statistically 
significantly different (p=0.16) [14]. At the 1 and 2 year follow-up visits, the 
prevalence of microalbuminuria (21.0% vs. 18.8% vs. 19.6%), or nephropathy 
(4.7% vs. 7.8% vs 5.4%) did not significantly change [24]. 
 
 
The DCCT demonstrated that with intensive insulin therapy, the 
development and progression of microalbuminuria was reduced by 39- 
54% in patients 13-39 years of age [44, 45, 46]. A similar reduction of 
microalbuminuria prevalence of 58% was seen in our total patient population 
once all patients were treated on a minimum of 3 insulin injections per day. 
 
Retinopathy 
During periods 1 and 2, no children with retinopathy were diagnosed.  
Whether all the children who qualified for screening actually attended their 
ophthalmology clinic appointments is not known. Circumstantial evidence 
suggests that attendance at that clinic was poor. During period 4, the policy 
was therefore changed and retinal photography was performed on the day the 
children attended the diabetes clinic. This is the most likely explanation for 
why most patients were screened during this time period (n=58). The 
prevalence of retinopathy in period 3 and 4 are comparable (13.3% vs. 
10.3%). This is slightly lower than the prevalence of mild non-proliferative 
retinopathy of 16.3% [17] found by R.W. Holl in a German study of paediatric 
and adolescent type 1 diabetics.   
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Neuropathy 
Only 1 patient in period 4 was found to have peripheral neuropathy. How 
neuropathy was excluded in period 1 is not known. Screening for vibration 
sense was only introduced late in period 3. Presumably neuropathy was not 
always excluded and therefore frequently missed. 
 
Studies from Australia indeed suggest that as a complication of diabetes, 
peripheral neuropathy should be more common than retinopathy. A cohort 
study done by F. Mohsin et al for example even demonstrated an increase in 
peripheral nerve abnormalities from 12% to 24% between 1990 and 2002 in 
adolescents aged 12-20 years [15]. E. Downie et al assessing adolescents 
aged 12-20 years, also demonstrated an increase in prevalence of peripheral 
nerve abnormalities from 7% to 14% between 1990 and 1999. This remained 
static at 14% until 2009 [23]. The Rwandan study by S.L. Marshall et al in 
2013 demonstrated a neuropathy rate of 21%, which was significantly 
associated with a higher mean age compared to those without neuropathy 
(23.0+1.6 years vs. 18.6+4.2 years, p=0.02) [14]. 
 
Limited joint mobility  
During period 1, LJM was never documented and therefore probably not 
routinely assessed. As the diabetes complication chart was introduced in the 
clinic, more patients were recognized with this complication, explaining the 
progressive increase in prevalence of LJM from 26% in period 2 to 42.9% in 
period 4.  
 
The prevalence of LJM, as established by the prayer manoeuvre (test to 
oppose palmar surfaces at the interphalangeal or metacarpophalangeal 
joints), varies significantly between studies: 7% in C. F. Clarke’s group from 
Australia (patients 8.6-18.5 years of age) [28], 26% in S. K. Garg’s group from 
the USA (patients more than 14 years of age) [32], 36.5% in L. Kennedy’s 
group from Belfast (patients 5-57 years of age) [30], 42% in J. E. H. Brice’s 
group from Nottingham (patients 2-16 years of age) [31], and 65.1% in E. 
Montaña’s group from Barcelona (patients more than 18 years of age) [29]. 
The prevalence found in our study is thus what would be expected from the 
literature. 
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Studies by Montana and Clark suggest that LJM may precede 
microangiopathy in adults and adolescents, making it a useful marker for the 
risk of developing microvascular complications such as microalbuminuria and 
retinopathy [29, 30, 32]. LJM was found in 90.0% of adult T1DM patients with 
microalbuminuria compared to only 57.4% of patients who had a normal 
urinary albumin excretion rate. In patients with retinopathy, joint mobility was 
more severely impaired and duration of diabetes was longer, compared to 
patients without retinopathy [29]. 
  
S. K. Garg also demonstrated an association of LJM with glycaemic control. 
The mean HbA1c level was higher (12.47% versus 11.73%) in patients14-34 
years of age with LJM than those without (p=0.0014) [32].  It was however not 
the aim of our study to look for associations between LJM and HbA1c, 
microalbuminuria or retinopathy. These analyses however could still be 
performed at a later stage. 
 
Lipid profiles 
The significant decrease of LDLC in period 3 (figure 11) is most likely the 
result of improved insulin therapy and better dietary control. The associated 
drop in HDLC is however of concern (figure 12). As this is the period with 
better glycaemic control, presumably diabetes itself is unlikely to account for 
this decrease. Instead it might be due to lack of physical activity.  Data on 
physical activity was however not obtained. BMIs were also not recorded 
during the study. We can only assume that the wider use of new technologies 
which were introduced in South Africa at the time, could inter alia have led to 
a more sedentary lifestyle.  
 
The overall prevalence of abnormal lipid profiles was as follows: borderline 
high/high TSC (TSC>5.2mmol/l) 29.9%, borderline high/ high/ very high LDLC 
(LDLC>3.4mmol/l) 28.7%, poor HDLC (HDLC<1mmol/l) 18.4% and borderline 
high/high TG concentration (TG >1.7mmol/l) 14.1%. The data suggests that 
our patient population has a much higher prevalence of abnormal lipid profiles 
than the SEARCH for Diabetes in Youth Study [27] as well as the study by 
Marcovecchio and Associates [25].  
 
The SEARCH for Diabetes in Youth Study demonstrates that 19% of type 1 
diabetics 10-22years of age have a TSC >5.2mmol/l, 15% have a 
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LDLC>3.4mmol/l, 12% have a HDLC<1mmol/l and 10% have a TG 
concentration >1.7mmol/l. This study does however have its limitations in that 
the participants were not a random sample and the rate of participants in the 
study was low especially amongst the older youth, possibly leading to an 
underestimation of dyslipidaemia [27]. 
  
Marcovecchio and Associates found a high prevalence of lipid abnormalities 
in their adolescent type 1 diabetic population (10-16 years of age). 
TSC>5.2mmol/l during follow-up was found to be 18.6%, 9.6% of the 
population had a high LDLC>3.4mmol/l, with HDLC<0.9mmol/l being only 
2.5%and TG concentration>1.7mmol/l being 20.1% of the population. 
Influencing factors on lipid abnormalities were found to be age and duration of 
diabetes (p<0.001). HbA1C was associated with all the abnormal lipid 
concentrations except HDLC (P<0.001), and BMI was associated with all the 
abnormal lipid concentrations except TSC (P<0.05) [25]. As with LJM, it was 
not the objective of the current study to look for any of these associations. 
 
A study performed by I Sylvester at Muhimbili National Hospital in Dar es 
Salaam in 2012, found a high TSC and LDLC of 25.5% and 29.6% 
respectively which is comparable to our study. Low HDLC and elevated TG 
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9 CONCLUSION AND RECOMMENDATIONS 
 
 
Diabetes care deteriorated after inexperienced personnel took over the 
management of diabetes patients at the Tygerberg Children’s Hospital. The care 
improved again after a paediatric endocrine specialist was re-employed and a 
DMT was implemented. It improved further after the appointment of a DNE. The 
following changes were observed: 
1. HbA1c decreased and showed less variation. 
2. DKA and rDKA rates were reduced. 
3. The number of admissions steadily decreased. 
4. The length of hospital stay initially increased for some patients as social 
and psychological issues of the patients were more readily identified. As 
these were addressed, the proportion of patients staying longer than a 
month reduced again. 
5. The number of insulin injections/day increased. More specifically the 
proportion of patients on the basal bolus regimen (intensive insulin 
regimen increased from 2.8% to 17.5%.  
6. Complications were more readily identified but the prevalence of the 
various complications was not reduced. 
7. The clinic attendance rate initially improved in an attempt to correct poor 
glycaemic control. Once this had been achieved the attendance rate 
dropped, but remained > 4 recommended annual visits in more than half 
the patients. 
 
This suggests that a multi-disciplinary approach to the management of diabetes 
plays a big role in the improved outcomes of paediatric diabetic patients. 
 
It is therefore recommended that inexperienced personnel should not be 
entrusted with the care of diabetes patients. For optimal care, the full DMT should 
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continue to perform its vital function. In particular, the service of the DNE is 
invaluable and every effort should be made to retain her position. 
 
This study should be repeated after another 2 years to assess ongoing 
improvement of all parameters. As a quality control assessment, the study should 
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